rdf:type |
|
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0017710,
umls-concept:C0029453,
umls-concept:C0030705,
umls-concept:C0073994,
umls-concept:C0087111,
umls-concept:C0205131,
umls-concept:C0205177,
umls-concept:C0442118,
umls-concept:C0445550,
umls-concept:C0549178,
umls-concept:C1522326,
umls-concept:C1704419
|
pubmed:issue |
11
|
pubmed:dateCreated |
1997-2-26
|
pubmed:abstractText |
To investigate the efficacy of intranasal salmon calcitonin (sCT) in treating axial bone loss in patients with rheumatoid arthritis (RA) taking low dose glucocorticoids.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0315-162X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1875-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8923359-Administration, Intranasal,
pubmed-meshheading:8923359-Adult,
pubmed-meshheading:8923359-Analgesics,
pubmed-meshheading:8923359-Arthritis, Rheumatoid,
pubmed-meshheading:8923359-Bone Demineralization, Pathologic,
pubmed-meshheading:8923359-Bone Density,
pubmed-meshheading:8923359-Bone and Bones,
pubmed-meshheading:8923359-Calcitonin,
pubmed-meshheading:8923359-Demography,
pubmed-meshheading:8923359-Female,
pubmed-meshheading:8923359-Glucocorticoids,
pubmed-meshheading:8923359-Humans,
pubmed-meshheading:8923359-Middle Aged
|
pubmed:year |
1996
|
pubmed:articleTitle |
Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy?
|
pubmed:affiliation |
Rheumatism Foundation Hospital, Heinola, Finland.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|